Ahmad S, Kenny M, Scribner B H
Clin Physiol Biochem. 1986;4(3):210-6.
Maintenance hemodialysis patients were randomly assigned to two groups based on the presence or absence of predialysis hypertension. Clinical profiles of the patients in the two groups were comparable except that there were more Blacks in the hypertensive group and that all the patients in this group received antihypertensive medications. Despite not taking any digitalis preparations, 10 of 12 hypertensives had measurable digoxin-like immunoreactive substance (DLIS) in their plasma. None of the 11 normotensives had detectable DLIS. Significantly higher (p less than 0.03) systemic vascular resistance was noted in hypertensives with DLIS compared to normotensives and hypertensives without DLIS. We propose that DLIS itself may be or may represent a marker for some vasopressive substance, possibly natriuretic hormone.
维持性血液透析患者根据透析前是否患有高血压被随机分为两组。两组患者的临床特征具有可比性,只是高血压组中的黑人更多,且该组所有患者都接受了抗高血压药物治疗。尽管未服用任何洋地黄制剂,但12名高血压患者中有10人的血浆中可检测到地高辛样免疫反应物质(DLIS)。11名血压正常的患者均未检测到DLIS。与血压正常者和无DLIS的高血压患者相比,有DLIS的高血压患者的全身血管阻力明显更高(p<0.03)。我们认为,DLIS本身可能是或可能代表某种血管加压物质的标志物,可能是利钠激素。